SS Innovations installs 30 SSi Mantra surgical robots in Q2 as revenue rises 39%
The Indian surgical robot maker has 224 systems in 12 countries, but margins fell and it is losing money again.
SS Innovations press imageSS Innovations, the Nasdaq-listed maker of the SSi Mantra surgical robot, which is developed and built in India, reported revenue of US$13.9 million for the quarter to June, up 39.4% on the year. It installed 30 SSi Mantra systems, up from 23 a year earlier. First-half revenue rose 65.6% to US$25.0 million.
The installed base reached 224 systems across 12 countries, and 12,272 surgeries have been done on them. Gross margin fell to 50.9% from 59.1%, and the net loss widened to US$2.7 million from US$0.3 million. Cash and equivalents, excluding restricted cash, were US$13.6 million at the end of June.
SSi Mantra competes on price with Intuitive's da Vinci in Indian hospitals. The company expects the US FDA to finish reviewing its 510(k) application by the end of the first quarter of 2027. US clearance is the main test of whether an Indian-built surgical robot can sell in the biggest market.
来源
本文由 AI 根据上方来源起草,发布前经 9DOF 编辑核查。数字以来源报道为准。发现错误? 告诉我们 我们会在本页更正。